3Ropper AH. The Guillain- Barre syndrome. N Engl J Med,1992, 326:1130- 1135
4Kieseier BC, Hartung HP. Therapeutic strategies in the Guillain- Barre syndrome. Semin Neurol, 2003, 23(2): 159-68
5Inoue N, Kunishige M, Yoshida S, et al. Dissociation between titer of anti - ganglioside antibody and severity of symptoms in a case of Guillain - Barre syndrome with treatment - related fluctuation. J Neurol Sci,2003, 15, 210(1-2): 105-108
6The Guillain- Barre syndrome Study Group. Plasmapheresis and acute Guillain - Barre syndrome. Neurology, 1985, 35:1096 - 1104
7Osterman PO, Fagius J, Lundemo G et al. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet, 1984, 2:1296- 1299
8French Cooperative Group on Plasma Exchange in Guillain- Barre syndrome. Efficiency of plasma exchange in Guillain- Barre syndrome: role of replacement fluids. Ann Neurol, 1987, 22: 753 - 761
9Assessment of plasmapheresis. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 1996,47:840-843
10Carbajal - Ramirez A, Castanon - Gonzalez JA, Osvaldo - Talavera J,et al. Plasmapheresis in Guillain - Barre syndrome. Gac Med Mex,2002, 138(6): 527 - 31
